Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
vTv Therapeutics (VTVT)
NASDAQ:VTVT
Holding VTVT?
Track your performance easily
VTVT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.38 - $31.20
Previous Close$23.75
Volume20.13K
Average Volume (3M)8.74K
Market Cap
$67.76M
Enterprise Value$24.73M
Total Cash (Recent Filing)$52.26M
Total Debt (Recent Filing)$298.00K
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Jul 31, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.87
Shares Outstanding3,010,206
10 Day Avg. Volume6,524
30 Day Avg. Volume8,741
Standard Deviation0.24
R-Squared0.02
Alpha-0.00202
Financial Highlights & Ratios
Price to Book (P/B)2.73
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.73
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
vTv Therapeutics News
PremiumCompany Announcements
vTv Therapeutics Faces License Agreement Termination
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VTVT FAQ
What was vTv Therapeutics’s price range in the past 12 months?
vTv Therapeutics lowest stock price was $7.38 and its highest was $31.20 in the past 12 months.
What is vTv Therapeutics’s market cap?
Currently, no data Available
When is vTv Therapeutics’s upcoming earnings report date?
vTv Therapeutics’s upcoming earnings report date is Jul 31, 2024 which is 118 days ago.
How were vTv Therapeutics’s earnings last quarter?
vTv Therapeutics released its earnings results on May 09, 2024. The company reported -$1.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.17.
Is vTv Therapeutics overvalued?
According to Wall Street analysts vTv Therapeutics’s price is currently Overvalued.
Does vTv Therapeutics pay dividends?
vTv Therapeutics does not currently pay dividends.
What is vTv Therapeutics’s EPS estimate?
vTv Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does vTv Therapeutics have?
vTv Therapeutics has 2,432,857 shares outstanding.
What happened to vTv Therapeutics’s price movement after its last earnings report?
vTv Therapeutics reported an EPS of -$1.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.131%.
Which hedge fund is a major shareholder of vTv Therapeutics?
Among the largest hedge funds holding vTv Therapeutics’s share is Baker Bros Advisors LP. It holds vTv Therapeutics’s shares valued at 2M.
---
vTv Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VTVT Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.8%
Last 30 Days ▲ 9.1%
Last 30 Days ▲ 9.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.96%
12-Months-Change
Fundamentals
Return on Equity
-2570.57%
Trailing 12-Months
Asset Growth
87.95%
Trailing 12-Months
Company Description
vTv Therapeutics
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
---
Technical Analysis
---